LONDON, United Kingdom, September, 2024 — Cambridge Healthcare Research (CHR) proudly announces Jeanne Penn as the new Vice President, US Commercial for its strategic competitive intelligence division, Solici. This appointment marks a significant step in CHR’s ongoing efforts to enhance its presence and impact in the US market.
Jeanne Penn, a seasoned leader in the biopharma industry, joins Solici from her previous roles at renowned organizations such as Genzyme (now Sanofi) and EMD Serono. At these companies, she led competitive intelligence, market research, and forecasting, specializing in rare diseases—an area where she has deep personal and professional passion. Jeanne’s vast experience also includes significant contributions at DRG (now Clarivate), Lifescience Dynamics, and Prescient Healthcare Group, where she led teams in delivering high-quality market analysis and insights.
Brendan Walkden, Head of Solici, expressed his enthusiasm about Jeanne’s appointment, stating, “Jeanne’s extensive industry experience and her strategic approach to growth are precisely what Solici needs at this pivotal time. We are thrilled to have her lead our US commercial operations.”
Stephen Galt, Chief Commercial Officer of CHR, also commented on the strategic addition, “Jeanne’s leadership qualities and her proven track record in fostering high-performing teams make her an invaluable asset as we expand our operations in the US. Her appointment is key to our strategy of deepening our engagement with US-based clients and enhancing our service offerings.”
Jeanne’s role will involve steering Solici’s strategic initiatives in the US, focusing on expanding the client base and ensuring that Solici continues to deliver competitive intelligence solutions that meet the complex demands of the healthcare and life sciences sectors.
About Cambridge Healthcare Research:
CHR is a leading consultancy that provides strategic decision support to the pharmaceutical, medical device, and consumer healthcare industries. Its division, Solici, specializes in competitive intelligence, helping healthcare decision-makers navigate complex market dynamics to make informed strategic choices.
Read Also : Imagination in a Disrupted Age: Navigating the Future with Curiosity and Empathy
